List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #40,401 to #40,450.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. PREVEND IT → Prevention Of Renal And Vascular End-Stage Disease Intervention Trial
  2. PREVENT(Radiation) → Proliferation Reduction With Vascular Energy Trial
  3. PREVENT (Dalteparin) → Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  4. PREVENT (Warfarin) → Venous thromboembolism
  5. PREVENT II → The Program In Ex Vivo Vein Graft Engineering Via Transfection II Study: E2F Decoy In Cabg
  6. PREVENT IV → Project Of Ex-Vivo Vein Graft Engineering Via Transfection
  7. PRF1 → Perforin
  8. PRIDE → A Prospective, Randomized, Controlled Trial Of Distal Protection With The Kensey-Nash Triactiv System Compared To The Guardwire Or Filterwire
  9. PRIMA — Presented at ACC.09/i2 → Can Pro-Brain Natriuretic Peptide Guided Therapy Of Heart Failure Improve Heart Failure Morbidity And Mortality?
  10. PRIME-2 → Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  11. PRIMI → Pro-Urokinase For Myocardial Infarction
  12. PRIMO-CABG → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  13. PRIMO-CABG II → Pexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  14. PRINCE → Effect Of Statin Therapy On C-Reactive Protein Levels: The Pravastatin Inflammation/Crp Evaluation (Prince): A Randomized Trial And Cohort Study
  15. PRINCESS → Prevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  16. PRINCIPLE-TIMI 44 → The Prasugrel In Comparison To Clopidogrel For Inhibition Of Platelet Activation And Aggregation–Thrombolysis In Myocardial Infarction 44 Trial
  17. PRISM → Platelet-Receptor Inhibition For Ischemic Syndrome Management
  18. PRISM-PLUS → Platelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  19. PRISM-Troponin → Troponin Levels Identify Cad Patients Likely To Benefit From Tirofiban: Results From The Prism-Troponin Study, A Substudy Of The Platelet Receptor Inhibition In Ischemic Syndrome Management Study
  20. PRISON II → Prospective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
  21. PRKACB gene → PRKACB
  22. PRKAR1A gene → PRKAR1A
  23. PRL cell adenoma → Prolactinoma
  24. PRL cell tumor → Prolactinoma
  25. PRL secreting adenoma → Prolactinoma
  26. PRL secreting pituitary adenoma → Prolactinoma
  27. PRL tumor → Prolactinoma
  28. PRNT → Plaque reduction neutralization test
  29. PROCAM → Simple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
  30. PRODH → Proline oxidase
  31. PROFILE → Prospective Randomized Flosequinan Longevity Evaluation
  32. PROGRESS → Perindopril Protection Against Recurrent Stroke Study
  33. PROGRESS-1 → Coronary Stenting With Absorbable Metal Stents
  34. PROLONG study → PROLONG Study
  35. PROM → Premature rupture of membranes
  36. PROMM → Myotonic dystrophy
  37. PROSPER → PROSPER Trial
  38. PROTECT-CAD → Prospective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
  39. PROTECT - TIMI 30 → Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
  40. PROTECT AF → Randomized Prospective Trial Of Percutaneous Left Atrial Appendage Closure Versus Warfarin For Stroke Prevention In Atrial Fibrillation
  41. PROTO oxidase → Protoporphyrinogen oxidase
  42. PROVED → Randomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
  43. PROVE IT-TIMI 22 (Gatifloxacin) → PROVE IT-TIMI 22 Trial
  44. PROVE IT/TIMI 22 → PROVE IT-TIMI 22 Trial
  45. PROVE IT Trial → PROVE IT-TIMI 22 Trial
  46. PROVIDENCE 1 → Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
  47. PROXIMAL → Proximal Protection During Saphenous Vein Graft Intervention
  48. PROactive → Prospective Pioglitazone Clinical Trial In Macrovascular Events
  49. PRP → Platelet rich plasma
  50. PRPP → Phosphoribosyl pyrophosphate

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"